Group 1 - Dr. Cheng Yanjie has resigned as a non-executive director of the company following the conclusion of the annual general meeting [1] - Mr. Diao Zhiqiang and Mr. Yu Bingming have been elected as independent non-executive directors by the shareholders at the annual general meeting [1] - Mr. Xu Dong'an has resigned as an independent non-executive director due to other business commitments, effective from December 19, 2025 [1] Group 2 - Changes to the board committee composition will take effect from December 19, 2025, following the annual general meeting [1] - Mr. Xu has resigned as the chairman of the nomination committee and as a member of the audit committee, remuneration committee, and nomination committee [1] - Ms. Guo Shuyi has been appointed as a member of the remuneration committee and nomination committee [1] - Mr. Liu Fei has been appointed as the chairman and a member of the nomination committee [1] - Mr. Diao has been appointed as a member of the audit committee, remuneration committee, and nomination committee [1] - Mr. Yu has been appointed as a member of the audit committee and nomination committee [1]
国药科技股份(08156)：余秉明获选举为独立非执行董事